Latest Comments on Richard Sater's Articles

1. Richard Sater on Novartis: Powering into the Multiple Sclerosis Market: Thank you for pointing out the error about Opexa and Novartis. ... more »
2. msviews_andnews on Novartis: Powering into the Multiple Sclerosis Market: MS Views and News (a 501©(3) organization) is dedicated to the... more »
3. msviews_andnews on Novartis: Powering into the Multiple Sclerosis Market: Unique in what we do. Bridging the gap to all major MS... more »
4. sleepdoc on BioMS: Hype or Hope? : Looks like the answer is Hype....very nice... more »
5. DennisA on BioMS: Hype or Hope? : Richard: Sorry, I'm "User 460167". I goofed up the entry. Have... more »
6. DennisA on BioMS: Hype or Hope? : Richard: I assume that Eli Lilly did extensive due dilligence... more »
7. Kyle Kimme on BioMS: Hype or Hope? : Thank you very much for your insight Richard. It is much appreciated. more »
8. steve1035 on BioMS: Hype or Hope? : Thanks again Richard for the info. For the phase II trial this is... more »
9. Richard Sater on BioMS: Hype or Hope? : Kyle: The 1/30/09 press release said “Dirucotide did meet... more »
10. steve1035 on BioMS: Hype or Hope? : Richard, appreciate your valuable analysis. Do you have any... more »
11. Kyle Kimme on BioMS: Hype or Hope? : Richard, Thanks for the quick response. Maybe I don't fully... more »
12. rrtzmd on BioMS: Hype or Hope? : ...that's easy -- HYPE!...or, more approriately --... more »
13. Richard Sater on BioMS: Hype or Hope? : Ivor and Kyle: Thank you for your comments. I'll try to address... more »
14. Kyle Kimme on BioMS: Hype or Hope? : Richard - If I'm reading correctly, it sounds as though you... more »
15. Ivor O'Shea on BioMS: Hype or Hope? : I think your article – while trying to be genuinely fair &... more »